Bee

Great Lakes farms have become a hot spot for bird flu, killing millions of birds and raising fears of a human pandemic.

Trump's federal funding cuts are shutting down studies on Alzheimer’s care, uterine fibroids and pregnancy risks — all because they focus on gender.

When the FDA announced in January, before President Joe Biden’s term ended, that it would ban a dye called red dye No. 3 in food and ingested drugs, the federal agency cited just one 1987 study on rats to support its action.

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their grant applications, two researchers said, in a move that signaled the agency might abandon a promising field of medical research.

A team of scientists at the Indiana University School of Medicine has identified that an eye condition affecting the retina, the light-sensing tissue in the back of the eye, may serve as an early indicator for Alzheimer's disease. Their findings, published in Alzheimer's & Dementia, offer new insights into the potential use of retinal changes as early biomarkers for Alzheimer's, which could improve diagnosis and treatment of neurodegenerative disease.

Scientists turned out at rallies from coast to coast and in Europe to “Stand Up for Science,” revitalizing a movement to defend scientific integrity that started during Trump’s first term.

A landmark study published in PNAS has unveiled that brain aging follows a distinct yet nonlinear trajectory with critical transition points. The research, conducted by an international team of scientists led by Lilianne R. Mujica-Parodi, PhD, of Stony Brook University, offers new insights into when interventions to prevent cognitive decline might be most effective.